EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics

Bogusława Konopska iD, Janusz Sokołowski iD, Anna Woźniak iD, Mikołaj Kondracki, Jakub Federowicz, Wojciech Grodzki, Agnieszka Bronowicka-Szydełko iD, Katarzyna Madziarska iD

Pharmaceutics · 20.01.2026 · 18 (1) · 130

DOI: 10.3390/pharmaceutics18010130 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 20.01.2026. Verfasst von Bogusława Konopska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Modern medicine requires effective, continuous, and safe therapies, which largely depend on the targeted delivery and activity of the drug. This goal can be achieved by designing drug delivery systems with improved pharmacokinetic properties and enhanced drug transport to the affected tissue. Human serum albumin (HSA) is an attractive carrier for the synthesis of therapeutic nanoparticles, several of which have already been approved by the United States Food and Drug Administration (FDA). The success of Abraxane as an effective treatment for metastatic breast cancer and non-small cell lung carcinoma, the application of Optison in ultrasound imaging, and the use of Nanocoll as an agent for SPECT diagnostics in sentinel node localisation confirm the strong potential of albumin-based systems. Further benefits are expected in patients with soft tissue cancers, as LadRx is seeking FDA marketing approval for Aldoxorubicin. The future of oncology lies in theranostics, which combines a tumour-localising factor on one platform with a drug targeting cancer cells and a factor that activates the cytotoxicity of the drug after it reaches the target tissue. This article presents recent advancements in albumin-based nanoparticles for drug delivery, targeting, and imaging. It also briefly discusses methods of synthesis and surface modification of albumin nanocarriers to enable targeted delivery to pathological sites. Finally, it outlines the latest approaches in multimodal theranostic platforms, highlighting albumin’s potential to improve cancer therapy.

Schlagwörter

Stichwörter der Autor:innen

albumindrug delivery systemsnanoparticlestheranostics

Autor:innen und Institutionen

  • Department of Laboratory Diagnostics, Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Department of Emergency Medicine, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Clinical Department of Diabetology, Hypertension and Internal Diseases, Faculty of Medicine, Wroclaw Medical University, 50-556 Wroclaw, Poland.
  • Faculty of Medicine, Wroclaw Medical University, 50-367 Wroclaw, Poland.
  • Department of Biochemistry and Immunochemistry, Faculty of Medicine, Wroclaw Medical University, 50-369 Wroclaw, Poland.

ORCID-Profile: Bogusława Konopska, Janusz Sokołowski, Anna Woźniak, Agnieszka Bronowicka-Szydełko, Katarzyna Madziarska

Zitieren

APA

Konopska, B., Sokołowski, J., Woźniak, A., Kondracki, M., Federowicz, J., Grodzki, W., Bronowicka-Szydełko, A., & Madziarska, K. (2026). Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics. Pharmaceutics, 18(1), 130. https://doi.org/10.3390/pharmaceutics18010130

Vancouver

Konopska B, Sokołowski J, Woźniak A, Kondracki M, Federowicz J, Grodzki W, et al. Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics. Pharmaceutics. 2026;18(1):130. doi:10.3390/pharmaceutics18010130

BibTeX
@article{Konopska2026,
  author = {Konopska, Bogusława and Sokołowski, Janusz and Woźniak, Anna and Kondracki, Mikołaj and Federowicz, Jakub and Grodzki, Wojciech and Bronowicka-Szydełko, Agnieszka and Madziarska, Katarzyna},
  title = {Albumin Nanoparticles as Multifunctional Carriers for Advanced Therapeutics},
  journal = {Pharmaceutics},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {130},
  doi = {10.3390/pharmaceutics18010130}
}
Kostenlos starten →